Praziquantel in treatment of cerebral schistosomiasis. (Q48300613)

10 February 2018

title

Praziquantel in treatment of cerebral schistosomiasis. (English)

1 reference

10 February 2018

0 references

1 reference

G Watt

1

1 reference

10 February 2018

B Adapon

2

1 reference

10 February 2018

G W Long

3

1 reference

10 February 2018

M T Fernando

4

1 reference

10 February 2018

C P Ranoa

5

1 reference

10 February 2018

J H Cross

6

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 September 1986

1 reference

10 February 2018

published in

The Lancet

1 reference

10 February 2018

volume

2

1 reference

10 February 2018

issue

8506

1 reference

10 February 2018

page(s)

529-532

1 reference

10 February 2018

Praziquantel: a major advance in anthelminthic therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Schistosomiasis japonica in Barrio San Antonio, Basey, Samar, in the Philippines. V. The enzyme-linked immunosorbent assay (ELISA) compared with quantitative stool examination and the circumoval precipitin (COP) test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Paragonimus and paragonimiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Experimental cerebral schistosomiasis japonica in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Cerebral schistosomiasis; report of a case with surgical removal of an intracerebral mass of schistosomal ova

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Schistosomiasis japonica with intracerebral granuloma; operative removal with recovery; report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Cerebral granuloma caused by Schistosoma japonicum.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Therapy of parenchymal brain cysticercosis with praziquantel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Successful praziquantel treatment of paragonimiasis following bithionol failure. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Recent advances in the diagnosis and treatment of cerebral cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Cysticercosis cerebri: evolution of central nervous system involvement as visualized by computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Childhood cerebral cysticercosis: clinical features and computed tomographic findings in 89 Mexican children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

Cysticercosis cerebri. Review of 127 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990110-8

7 January 2021

10.1016/S0140-6736(86)90110-8

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

2875279

1 reference

10 February 2018